Editorial: Recent advances in thromboembolism and oral contraceptives. [PDF]
Morimont L, Foidart JM.
europepmc +1 more source
Multicentre Trial Evaluating the Safety and Tolerability of Estetrol-Drospirenone Combined Oral Contraceptive in Postmenarchal Female Adolescents. [PDF]
Lindén Hirschberg A +7 more
europepmc +1 more source
Clinical and endocrine effects of pharmacological therapy in endometriosis: a systematic review and meta-analysis. [PDF]
Sun R, Xu H, Ma R, Xu J, Liu Y, Mao D.
europepmc +1 more source
Comparison of Substances in Combined Oral Contraceptives Used in Acne Vulgaris, Hirsutism, Migraine, and Dysmenorrhea. [PDF]
Wójcikiewicz P +4 more
europepmc +1 more source
Drug-drug interactions between sex hormones and analgesics linked to thromboembolic events: an FDA adverse event reporting system analysis. [PDF]
Yamazaki S, Onda K, Masuyama K.
europepmc +1 more source
Case Report: Menstrual cycle-related psychosis in bipolar I disorder, remitting with a combined oral contraceptive. [PDF]
Hanyu S, Yoshimoto K, Shimizu N.
europepmc +1 more source
Pyoderma gangrenosum in a 26-year-old woman. [PDF]
Khan MN, Asamoah N, Pathayappura SK.
europepmc +1 more source
Contraceptive Progestogens and Incident Meningioma.
Hasselblad Lundstrøm N +4 more
europepmc +1 more source
Impact of estetrol and drospirenone combination therapy on alleviation of the pelvic pain of endometriosis: a randomized control trial. [PDF]
Harada T +6 more
europepmc +1 more source
Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives. [PDF]
Morimont L +4 more
europepmc +1 more source

